Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 6, 2002, Pages 1741-1745

  Lesic, Biliana ^a   Foulon, Jeannine ^a   Carniel, Elisabeth ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DEFERIPRONE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; IRON; IRON CHELATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG STRUCTURE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; IRON CHELATION; LD 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; YERSINIA ENTEROCOLITICA;

2,2'-DIPYRIDYL; ANIMALS; CHELATING AGENTS; CULTURE MEDIA; DEFEROXAMINE; IRON CHELATING AGENTS; KINETICS; MICE; MICROBIAL SENSITIVITY TESTS; PYRIDONES; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 0036090462     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.6.1741-1745.2002     Document Type: Article

References (17)

1. Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: Incidence and predisposing factors
2. Meta-analytic review of the clinical effectiveness of oral deferiprone (L1)
3. Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages
4. Desferrioxamine-promoted virulence of Yersinia enterocolitica in mice depends on both desferrioxamine type and mouse strain
5. Deferiprone: A review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases
6. Ferrioxamine uptake in Yersinia enterocolitica: Characterization of the receptor protein FoxA
7. The effect of synthetic iron chelators on bacterial growth in human serum
8. Expression of iron-regulated proteins in Yersinia species and their relation to virulence
9. Prospective study of Yersinia enterocolitica infection in thalassemic patients
10. Safety profile of the oral iron chelator deferiprone: A multicentre study
11. Homozygous beta-thalassemia: A review of patients who had splenectomy at the Royal Alexandra hospital for children
12. Iron chelation therapy
13. Survival in beta-thalassemia major in the UK: Data from the UK Thalassemia Register
14. Specificity and mechanism of ferrioxamine-mediated iron transport in Streptomyces pilosus
15. Invasive disease due to Yersinia enterocolitica in children with beta-thalassemia major
16. A simple method of estimating fifty per cent endpoints
17. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica